Thomas J. Kipps

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 37 papers. Top paper: “Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study”.

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study

Journal of Clinical Oncology(2020)10.1200/jco.20.00948

N/A

4.9DataRank · unranked

223 citations

Jenny Wu, Thomas J. Kipps, Barbara Eichhorst, Peter Hillmen, James D’Rozario +23 more

Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab

Blood(2022)10.1182/blood.2021015014

N/A

3.8DataRank · unranked

153 citations

Thomas J. Kipps, Barbara Eichhorst, James D’Rozario, Carolyn Owen, Sarit Assouline +16 more

Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0276

N/A

1.5DataRank · unranked

64 citations

Satyen H. Gohil, Caleb A. Lareau, Leif S. Ludwig, Erin M. Parry, Teddy Huang +15 more

Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-06914-2

N/A

0.441DataRank · unranked

7 citations

Rebecca Shatsky, Richard B. Schwab, Anne M. Wallace, Denise M. Wolf, Gillian L. Hirst +7 more

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576

Advances in Hematology(2022)10.1155/2022/4450824

N/A

0.308DataRank · unranked

3 citations

Paula A. Lengerke-Diaz, Juliana Vélez Luján, Michael Y. Choi, Eider Moreno-Cortes, José Vicente Forero-Forero +7 more

Robust integration of single-cell cytometry datasets

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.28.450128

N/A

0.267DataRank · unranked

2 citations

Søren Helweg Dam, Mike Bogetofte Barnkob, Michael D. Leipold, Noelia Purroy, Laura Z. Rassenti +7 more

A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation

Cancer Cell(2021)10.1016/j.ccell.2021.02.003

N/A

0DataRank · unranked

60 citations

Shanye Yin, Elisa Ten Hacken, Tomasz Sewastianik, Mohamed Uduman, Alba Font‐Tello +24 more

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01032-2

N/A

0DataRank · unranked

54 citations

Zachary A. Hing, Bonnie K. Harrington, J.M. Baumhardt, Hatice Gülçin Özer, Amy Lehman +22 more

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

Leukemia(2021)10.1038/s41375-021-01344-9

N/A

0DataRank · unranked

22 citations

J. Brice Weinberg, Sameer A. Parikh, Esteban Braggio, Sara J. Achenbach, Dennis P. Robinson +17 more

Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

Cancer Research(2021)10.1158/0008-5472.can-21-1273

N/A

0DataRank · unranked

22 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

FD-895 and Pladienolide B Modulate RNA Splicing Associated With Wnt Signaling Pathway

Research Square(2021)10.21203/rs.3.rs-768225/v1

N/A

0DataRank · unranked

0 citations

Manoj Kumar Kashyap, Zhe Yu, Ide Spaanderman, Reymundo Villa, Thomas J. Kipps +4 more

Ibrutinib plus obinutuzumab as frontline therapy for chronic lymphocytic leukemia is associated with a lower rate of infusion-related reactions and with sustained remissions after ibrutinib discontinuation: a single-arm, open-label, phase 1b/2 clinical trial NCT0231576

Research Square(2021)10.21203/rs.3.rs-887972/v1

N/A

0DataRank · unranked

0 citations

Paula A. Lengerke-Diaz, Juliana Velez-Lujan, Michale Y. Choi, Eider Moreno-Cortes, José Vicente Forero-Forero +7 more

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Nature Genetics(2022)10.1038/s41588-022-01140-w

N/A

0DataRank · unranked

150 citations

Ziao Lin, Cynthia K. Hahn, Ferran Nadeu, Martí Duran‐Ferrer, Kristen E. Stevenson +34 more

cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies

Nature Communications(2022)10.1038/s41467-022-29383-5

N/A

0DataRank · unranked

127 citations

Søren Helweg Dam, Mike Bogetofte Barnkob, Michael D. Leipold, Noelia Purroy, Laura Z. Rassenti +7 more

ROR1: an orphan becomes apparent

Blood(2022)10.1182/blood.2021014760

N/A

0DataRank · unranked

82 citations

Thomas J. Kipps

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia

Leukemia(2022)10.1038/s41375-022-01543-y

N/A

0DataRank · unranked

31 citations

Laura Z. Rassenti, Michael Y. Choi, Miguel Quijada‐Álamo, Elvin Chu, George F. Widhopf +2 more

Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib

Blood(2022)10.1182/blood.2021013926

N/A

0DataRank · unranked

18 citations

Yuzhou Evelyn Tong, Camilla K. Lemvigh, Nicoletta Cieri, Shuqiang Li, Erin M. Parry +17 more

Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B

Aging(2022)10.18632/aging.203924

N/A

0DataRank · unranked

4 citations

Manoj Kumar Kashyap, Zhe Yu, Ide Spaanderman, Reymundo Villa, Thomas J. Kipps +4 more

Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia

Frontiers in Oncology(2022)10.3389/fonc.2022.897280

N/A

0DataRank · unranked

3 citations

Xiao‐Jie Yan, Wentian Li, Emanuela M. Ghia, Anton W. Langerak, Laura Z. Rassenti +22 more

Dysregulated Spliceosome Activity Involves Increased Intron Retention Plus Upregulation and Phosphorylation of SF3B1 in Chronic Lymphocytic Leukemia

Research Square(2022)10.21203/rs.3.rs-1622375/v1

N/A

0DataRank · unranked

0 citations

Hiren Karathia, Deepak Kumar, Roberto Vera Alvarez, Paula A. Lengerke-Diaz, José Vicente Forero-Forero +15 more

Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome

Nature Medicine(2023)10.1038/s41591-022-02113-6

N/A

0DataRank · unranked

83 citations

Ignaty Leshchiner, Romain Guièze, Connor Johnson, Eugen Tausch, Sameer A. Parikh +49 more

Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2307593120

N/A

0DataRank · unranked

13 citations

Giovanni Nigita, Liudmyla Tsyba, Alexey Palamarchuk, Salvatore Alaimo, Alfredo Pulvirenti +7 more

Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway

Oncotarget(2023)10.18632/oncotarget.28386

N/A

0DataRank · unranked

3 citations

Thomas J. Kipps, Md Kamrul Hasan

Relapse after First-Line Fixed Duration Ibrutinib + Venetoclax: High Response Rates to Ibrutinib Retreatment and Absence of BTK Mutations in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) with up to 5 Years of Follow-up in the Phase 2 Captivate Study

Blood(2023)10.1182/blood-2023-187128

N/A

0DataRank · unranked

39 citations

William G. Wierda, Paul M. Barr, Thomas J. Kipps, Tanya Siddiqi, John N. Allan +6 more

Data from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181

(2023)10.1158/0008-5472.c.6495971

N/A

0DataRank · unranked

0 citations

Urmila Santanam, Amelia Cimmino, Alexey Palamarchuk, A. V. Efanov, Vadim Maximov +9 more

Data from Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181

(2023)10.1158/0008-5472.c.6495971.v1

N/A

0DataRank · unranked

0 citations

Urmila Santanam, Amelia Cimmino, Alexey Palamarchuk, A. V. Efanov, Vadim Maximov +9 more

Data from Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia

(2023)10.1158/0008-5472.c.6513540.v1

N/A

0DataRank · unranked

0 citations

Shanye Yin, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas +26 more

Data from Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History

(2023)10.1158/2159-8290.c.6549383.v1

N/A

0DataRank · unranked

0 citations

Satyen H. Gohil, Caleb A. Lareau, Leif S. Ludwig, Erin M. Parry, Teddy Huang +15 more

Mutation in Bruton Tyrosine Kinase (BTK) A428D confers resistance To BTK-degrader therapy in chronic lymphocytic leukemia

Leukemia(2024)10.1038/s41375-024-02317-4

N/A

0DataRank · unranked

31 citations

Michael Y. Choi, Huan‐You Wang, Thomas J. Kipps, Richard Wong

Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102202

N/A

0DataRank · unranked

3 citations

Hiren Karathia, Deepak Kumar, Roberto Vera Alvarez, Jose Vicente Forero-Forero, Eider Moreno +15 more

Wnt5a induces ROR1 dependent NF-κB activation to enhance MMP-9 expression and invasiveness in chronic lymphocytic leukemia

Leukemia(2025)10.1038/s41375-025-02616-4

N/A

0DataRank · unranked

7 citations

George F. Widhopf, Emanuela M. Ghia, Thomas J. Kipps, Md Kamrul Hasan

SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway

JCI Insight(2025)10.1172/jci.insight.184280

N/A

0DataRank · unranked

2 citations

Prajish Iyer, Meiling Jin, Elisa Ten Hacken, Zachary Cartun, Kevyn L. Hart +13 more

NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia

Cell Death and Differentiation(2020)10.1038/s41418-020-0496-1

N/A

0DataRank · unranked

51 citations

Emanuela M. Ghia, Laura Antonucci, Natasha Sharma, Laura Z. Rassenti, Jinyi Xu +4 more

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect

Science Translational Medicine(2020)10.1126/scitranslmed.abb7661

N/A

0DataRank · unranked

24 citations

Christina Ennis, Vinhkhang N. Nguyen, Satyen H. Gohil, Kendell Clement, Sachet A. Shukla +22 more

Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism

Leukemia(2020)10.1038/s41375-020-01055-7

N/A

0DataRank · unranked

39 citations

Emanuela M. Ghia, Laura Z. Rassenti, George F. Widhopf, Thomas J. Kipps, Md Kamrul Hasan

Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy

Blood Cancer Discovery(2020)10.1158/2643-3230.bcd-19-0058

N/A

0DataRank · unranked

30 citations

Anat Biran, Noelia Purroy, Camilla K. Lemvigh, Kendell Clement, Michaela Gruber +22 more

Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to graft-versus-leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.09.033555

N/A

0DataRank · unranked

0 citations

Christina Ennis, Vinhkhang N. Nguyen, Kendell Clement, Satyen H. Gohil, Sachet A. Shukla +20 more